Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18–18 and EGFR amplification: A case report

por Wang, Pascal, Fabre, Emmanuelle, Martin, Antoine, Chouahnia, Kader, Benabadji, Ambre, Matton, Lise, Duchemann, Boris
Publicado 2022